Literature DB >> 1911807

Toxoplasmosis and heart transplantation.

R E Holliman1, J D Johnson, S Adams, J R Pepper.   

Abstract

Our experience of toxoplasmosis in a series of 33 heart transplant cases was reviewed. One fatal infection was observed in a "mismatched" seronegative recipient of a heart from a seropositive donor. Two similar mismatched cases were given pyrimethamine prophylaxis and remained well. One organ recipient was found to have primary toxoplasmosis during the immediate preoperative assessment. The patient was treated with conventional therapy and remained asymptomatic in the postoperative period. Secondary reactivation of chronic infection and diagnostic confusion caused by passively acquired antibody associated with blood transfusion were not recorded. False reactions were noted in dye and latex agglutination test results.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911807

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  4 in total

1.  PCR for diagnosis and follow-up of two cases of disseminated toxoplasmosis after kidney grafting.

Authors:  D Aubert; F Foudrinier; I Villena; J M Pinon; M F Biava; E Renoult
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

2.  Sulfadiazine therapy for toxoplasmosis in heart transplant recipients decreases cyclosporine concentration.

Authors:  C H Spes; C E Angermann; H U Stempfle; K Wenke; K Theisen
Journal:  Clin Investig       Date:  1992-09

3.  LDBio-Toxo II immunoglobulin G Western blot confirmatory test for anti-toxoplasma antibody detection.

Authors:  Jacqueline Franck; Yves Jean-François Garin; Henri Dumon
Journal:  J Clin Microbiol       Date:  2008-05-14       Impact factor: 5.948

4.  Toxoplasmosis in heart transplant recipients.

Authors:  A Gallino; M Maggiorini; W Kiowski; X Martin; W Wunderli; J Schneider; M Turina; F Follath
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.